Who are I-O Urology's investors?

I-O Urology's investors include Jumpstart Capital, Solas BioVentures.

How much funding has I-O Urology raised?

I-O Urology has disclosed $16.1M raised across 2 rounds.

Where is I-O Urology headquartered?

I-O Urology is headquartered in Knoxville, US.

I-O Urology

Knoxville, US · Founded 2020 · 2 known investors

Find your way into I-O Urology

Paths you didn't know you had: your email and LinkedIn already hold routes to the I-O Urology team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions. Serves patients experiencing urinary symptoms and their clinicians in the urology care space.

Digital Health Hardware Medical Devices

Founders & leadership

Ryan WilemsenExecutive

Stephen Grady ArnoldExecutive

Britton Alan GarrettExecutive

John GreenNamed on SEC filing

Brent LaingNamed on SEC filing

Brad RouseNamed on SEC filing

David GilliamNamed on SEC filing

Board

David Adair Board directorCo-Founder and Managing Director at Solas BioVentures

Josh EckelberryBoard director

Steve BlumBoard director

Tyler BinneyBoard director

Investors · 2

Jumpstart Capitallisted by Jumpstart CapitalNashville · $250K – $500K

How we know: Jumpstart Capital's portfolio page · Not right? Tell us

Solas BioVentureslisted by Solas BioVenturesChattanooga

How we know: Solas BioVentures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$16.1M disclosed across 2 rounds · 2023–2025

▶$85.4KraisedNov 2025 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Steve BlumDirector
Josh EckelberryDirector
Ryan WilemsenExecutive Officer
Stephen Grady ArnoldExecutive Officer
Tyler BinneyDirector
Britton Alan GarrettExecutive Officer, Director
Brent LaingExecutive Officer, Director

Offering amount: $6.6M
Amount sold: $85.4K
First sale: Oct 2025
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$16MraisedJan 2024 · 21 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

David AdairDirector
John GreenExecutive Officer
Britton GarrettExecutive Officer, Director
Brent LaingExecutive Officer, Director
Josh EckelberryDirector
Brad RouseDirector
David GilliamExecutive Officer

Offering amount: $19.3M
Amount sold: $16M
Proceeds to insiders: $281.1K
First sale: Dec 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does I-O Urology do?: Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions. Serves patients experiencing urinary symptoms and their clinicians in the urology care space.
Who are I-O Urology's investors?: I-O Urology's investors include Jumpstart Capital, Solas BioVentures.
How much funding has I-O Urology raised?: I-O Urology has disclosed $16.1M raised across 2 rounds.
Where is I-O Urology headquartered?: I-O Urology is headquartered in Knoxville, US.